CaitrionaRyanMDFAAD, MB, BCh, BAO, BMedSc, MRCPI

PubMed

• 334 citations
  Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-...
  Alan Menter, Neil J. Korman, Craig A. Elmets, Steven R. Feldman, Joel M. Gelfand
  Journal of the American Academy of Dermatology. 2011-07-01
• 116 citations
  From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis
  April W. Armstrong, Michael P. Siegel, Jerry Bagel, Erin E. Boh, Megan Buell
  Journal of the American Academy of Dermatology. 2017-02-01
• 32 citations
  Patients’ Perspectives on the Impact of Genital Psoriasis: A Qualitative Study
  Jennifer Clay Cather, Caitriona Ryan, K.A.P. Meeuwis, Alison Potts Bleakman, April N. Naegeli
  Dermatology and Therapy. 2017-10-26

Journal Articles

• Biologics in practice: using biologic agents in combination with methotrexate in psoriasis therapy. The Dermatologist 2014; 21: 28-31  
  Haugh I, Ryan C, Menter A., The Dermatologist, 3/2014
• Ryan C. Continuing the dialogue: the future of psoriasis.  
  Ryan C., Psoriasis Review, 12/2012
• Are drug treatments for psoriasis a cardiovascular risk? Clinical Practice 2012  
  Ryan C, Patel M, Menter A., Clinical Practice, 2012
• The use of pharmacogenomics in psoriasis. Clinical Investigation 2011  
  Ryan C, Bowcock A, Menter A., Clinical Investigation, 3/2011
• Biologic Therapies for Chronic Plaque Psoriasis and Cardiovascular Events—Reply [letter].  
  Ryan C, Daoud Y, Menter A., JAMA, 2011
• Neuropeptides and psoriasis.  
  Ryan C, Kirby B., G Ital Dermatol Venereol, 10/2007
• Join now to see all

Books/Book Chapters

• Psoriasis: Diagnosis and Management 
  Chapter: Recent and future developments in targeted therapy 
  Ryan C, Menter AEditors: Sterry W.Wiley-BlackwellEdition 1,2014
• Advances in Psoriasis 
  Chapter: Ustekinumab 
  Ryan C, Leonardi CEditors: Weinberg J.Springer2014
• Brenner's Online Encyclopedia of Genetics 
  Chapter: Psoriasis 
  Page 524 - 526Ryan C, Bowcock AM, Menter AEditors: Maloy S, Hughes Kelly.Academic PressEdition 2nd,2013

Abstracts/Posters

• Genital psoriasis is associated with significant impairment in quality of life and sexual functioning
  Ryan C, Sadlier M, Patel M, Kirby B, Menter A, International Investigative Dermatology Meeting, Edinburgh, Scotland, 3/1/2013
• Systems analysis of pneumococcal vaccine response in psoriasis patients
  Obermoser G, Ryan C, Ruchaud E, Mansouri B, Patel M, Palucka K, Menter A, International Investigative Dermatology Meeting, Edinburgh, Scotland, 3/1/2013
• Genital psoriasis is associated with significant impairment in quality of life and sexual functioning
  Ryan C, Sadlier M, Patel M, Kirby B, Menter A, J Invest Dermatol, 1/1/2013
• Systems analysis of pneumococcal vaccine response in psoriasis patients
  Obermoser G, Ryan C, Ruchaud E, Mansouri B, Patel M, Palucka K, Menter A, J Invest Dermatol, 1/1/2013
• Alterations in leukocyte subsets in the blood of psoriasis patients
  Obermoser G, Ryan C, Banchereau J, Pascual V, Chaussabel D, Menter A, Society of Investigational Dermatology Annual Meeting, Phoenix, AZ, 5/1/2011
• Antagonism of p40 cytokines in psoriasis patients may promote paradoxical cardiovascular risk; a meta-analysis of randomized controlled trials and report of a consensu...
  Ryan C, Leonardi CL, Krueger JG, Kimball AB, Strober BE, Gordon KB, Langley RG, Kaplan DH, Menter A, Annual Meeting of Society of Investigative Dermatology, Phoenix, AZ, 5/1/2011
• Antagonism of p40 cytokines in psoriasis patients may promote paradoxical cardiovascular risk; a meta-analysis of randomized controlled trials and report of a consensu...
  Ryan C, Leonardi CL, Krueger JG, Kimball AB, Strober BE, Gordon KB, Langley RG, Kaplan DH, Menter A, J Invest Dermatol, 1/1/2011
• Alterations in leukocyte subsets in the blood of psoriasis patients
  Obermoser G, Ryan C, Banchereau J, Pascual V, Chaussabel D, Menter A, J Invest Dermatol, 1/1/2011
• The use of transcriptional profiling to evaluate psoriasis as a systemic disease
  Ryan C, Obermoser G, Banchereau R, Lemoine B, Pascual V, Banchereau J, Chaussabel D, Menter A, European Association of Dermatology and Venereology Annual Meeting; Society of Investigational Dermatology Annual Meeting, Atlanta, GA, 5/1/2010
• Clinical and genetic predictors of response to narrowband UVB in the treatment of chronic plaque psoriasis
  Ryan C, Renfro L, Collins P, Kirby B, Roger S, Br J Dermatol, 1/1/2010
• The use of transcriptional profiling to evaluate psoriasis as a systemic disease
  Ryan C, Banchereau R, Obermoser G, Lemoine B, Pascual V, Banchereau J, Chaussabel D, Menter A, J Invest Dermatol, 1/1/2010
• HLA-Cw*0602 as a predictor of response to TNF inhibitors in the treatment of chronic plaque psoriasis
  Ryan C, Kirby B, British Association of Dermatology Meeting, Glasgow, Scotland, 7/1/2009
• A study to examine if the HLACw* 0602 allele is a predictor of response to TNF-a inhibitors in the treatment of psoriasis
  Ryan C, Kelleher J, Collins P, Rogers S, Kirby B, Br J Dermatol, 1/1/2009
• Treatment of acrodermatitis continua of Hallopeau with adalimumab, Psoriasis Gene to Clinic
  Ryan C, Collins P, Kirby B, Rogers S, London, England, 12/1/2008
• Treatment of acrodermatitis continua of Hallopeau with adalimumab, Psoriasis Gene to Clinic
  Ryan C, Collins P, Kirby B, Rogers S, London, England, 12/1/2008
• Adalimumab Treatment for Severe Recalcitrant Psoriasis
  Ryan C, Kirby B, Collins P, Rogers S, British Association of Dermatology Meeting, Liverpool, England, 7/1/2008
• Two years' experience with adalimumab in severe, recalcitrant psoriasis
  Ryan C, Kirby B, Collins P, Rogers S, Br J Dermatol, 1/1/2008
• Treatment of acrodermatitis continua of Hallopeau with adalimumab
  Ryan C, Collins P, Kirby B, Rogers S, Br J Dermatol, 1/1/2008
• Redefining outlook for survivors of class IV heart failure admission: Long term follow up of 536 patients in a hospital based disease management programme
  O'Loughlin C, Murphy N, Conlon C, Traynor T, Ryan C, Ledwidge M, McDonald K, Eur J Heart Fail, 1/1/2006
• Growing Awareness and Changing Trends In Prevention Of Glucocorticoid-induced Osteoporosis, 2002-2006. A Re-audit
  Mohammad A, Ryan JG, Ralph N, Ryan C, O'Connell PG, Arth+Rheum, 1/1/2006
• Diastolic and Systolic Heart failure patients derive similar benefit from a hospital based disease management program: 3 year follow up of 438 patients
  Martos R, Conlon C, O Loughlin C, Traynor C, Ryan C, Ledwidge M, Mc Donald K, Eur J Heart Fail, 1/1/2005
• Defining a new outlook for survivors of class IV heart failure admission: 3 year followup of 477 patients managed in a hospital based disease management program
  Conlon C, O'Loughlin C, Ryan C, Traynor C, Martos R, Ledwidge M, McDonald K, Eur J Heart Fail, 1/1/2005
• Join now to see all

Lectures

• “The Shifting Paradigm in Psoriasis Treatment,” 
  International Psoriasis Council Meeting, Dallas, TX - 4/10/2014
• Research Gaps in Psoriasis: Genetics and Pathophysiology 
  Denver, CO - 3/1/2014
• TNF-alpha antagonists and p40 antibodies in psoriasis: similarities and differences 
  Stockholm, Sweden - 6/1/2012
• Practical Case Management in Psoriasis 
  Dublin, Ireland - 5/1/2012
• Psoriasis; what lies beneath 
  Dublin, Ireland - 5/1/2012
• The effect of biologic treatments on cardiovascular risk in psoriasis 
  Dallas, TX - 11/1/2011
• LEO 80185-G23 Guide to Clinical Assessments 
  San Antonio, TX - 9/1/2011
• The association between biologic treatments for psoriasis and cardiovascular risk 
  London, England - 7/1/2011
• Anti-IL-12/23 agents and JAK inhibitors for the treatment of psoriasis: a review 
  Dallas, TX - 5/1/2011
• Antagonism of p40 cytokines in psoriasis patients may promote paradoxical cardiovascular risk; a meta-analysis of randomized controlled trials and report of a consensu... 
  Phoenix, AZ - 5/1/2011
• Clinical and genetic predictors of response to narrowband UVB in the treatment of chronic plaque psoriasis 
  Manchester, England - 7/1/2010
• A review of the safety profile of ustekinumab 
  Manchester, England - 7/1/2010
• The effect of narrowband ultraviolet B treatment for psoriasis on vitamin D status during wintertime in Ireland 
  Miami, FL - 3/1/2010
• Traditional systemic therapies for the treatment of psoriasis 
  Dallas, TX - 11/1/2009
• Anti-IL12/23 antibodies in the treatment of psoriasis/psoriatic arthritis 
  Dallas, TX - 11/1/2009
• CMV induced vasculopathy and perianal ulceration 
  San Francisco, CA - 3/1/2009
• Cryoglobulin associated angiomatosis 
  San Francisco, CA - 3/1/2009
• Updates in Psoriasis 
  Dublin, Ireland - 3/1/2009
• Adalimumab Treatment for Severe Recalcitrant Psoriasis 
  Dublin, Ireland - 4/1/2008
• Folliculotropic and Ichthyosiform Mycosis Fungoides 
  London, England - 12/1/2007
• Necrotising Lesions of the Male Genitalia 
  Dublin, Ireland - 9/1/2006
• Join now to see all